For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Oncothyreon Inc.

USPTO Granted Patents = 10

% Expired Patents = 90.0

CIPO Patents = 1

EPO Patents = 9

Forward Citations = 58

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

B Michael Longenecker (5 out of 14 patents)

Wladyslaw A Budzynski (4 out of 4 patents)

R Rao Koganty (4 out of 7 patents)

4. Scott Peterson (2 out of 5 patents)

5. Linda Pestano (2 out of 2 patents)

6. Diana F Hausman (2 out of 4 patents)

7. Jeffrey Millard (2 out of 2 patents)

8. Sandy Koppenol (2 out of 3 patents)

9. Robert Kirkman (2 out of 2 patents)

10. Mark J Krantz (2 out of 3 patents)

11. Zi-Hua Jiang (2 out of 3 patents)

12. Zi-hua Jiang (1 out of 3 patents)

13. Damayanthi Yalamati (1 out of 3 patents)

14. Myung-Gi Baek (1 out of 1 patent)

15. Rao R Koganty (1 out of 3 patents)

10 patents: Sort by Forward Citations

1. 9173929 - Mucinous glycoprotein (MUC-1) vaccine (2015-11-03),

2. 9119784 - Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine (2015-09-01),

3. 8889616 - MUC1 based glycolipopeptide vaccine with adjuvant (2014-11-18),

4. 8871250 - Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine (2014-10-28),

5. 8552145 - Vaccine for modulating between T1 and T2 immune responses (2013-10-08),

6. 8329639 - MUC1 based glycolipopeptide vaccine with adjuvant (2012-12-11),

7. 8198400 - Vaccine for modulating between T1 and T2 immune responses (2012-06-12),

8. 8097593 - Lipid A and other carbohydrate ligand analogs (2012-01-17),

9. 7820627 - Lipid A and other carbohydrate ligand analogs (2010-10-26),

10. 7741297 - Immunostimulatory, covalently lipidated oligonucleotides (2010-06-22),

Oncothyreon is a biotechnology company focused on the development of innovative oncology products for the treatment of cancer. With a pipeline of promising drug candidates and a team of experienced researchers, Oncothyreon is committed to advancing novel therapies that have the potential to improve patient outcomes and quality of life.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

10 Patents

#199 in Seattle, WA

#683 in Washington

#29,781 in US

#55,883 in the World

Seattle, WA, United States of America

Oncothyreon Inc.

Forward Citations = 58

15 inventors:

B Michael Longenecker (5 out of 14 patents)

Wladyslaw A Budzynski (4 out of 4 patents)

R Rao Koganty (4 out of 7 patents)

4. Scott Peterson (2 out of 5 patents)

5. Linda Pestano (2 out of 2 patents)

Please report any incorrect information to [email protected]

Loading…